Menovazin alcohol solution for external use bottle 40 ml

Instructions for use Menovazin alcohol solution for external use, bottle 40 ml

Composition

active ingredients: racemic menthol, procaine hydrochloride, benzocaine;
100 ml of solution contains 2.5 g of racemic menthol, 1 g of procaine hydrochloride, 1 g of benzocaine;
excipient: ethanol 70%.

Dosage form

Solution for external use, alcohol.

Main physicochemical properties: clear colorless liquid with a menthol odor.

Pharmacotherapeutic group

Topical agents for joint and muscle pain.
ATX code M02A X.

Pharmacological properties

Pharmacodynamics.

The drug has an antipruritic and local anesthetic effect. When applied to the skin and mucous membranes, it causes irritation of nerve endings, which is accompanied by a feeling of cold, slight burning and tingling.

Has a mild analgesic effect.

Pharmacokinetics.

When applied topically, the drug does not enter the bloodstream.

Indication

The drug is prescribed for neuralgia, myalgia, and arthralgia.

Contraindication

The drug is contraindicated in case of hypersensitivity to novocaine and other components of the drug.

Special safety precautions

Do not apply to damaged skin or skin with allergic manifestations. Do not apply to facial skin.

You should not violate the rules for using the medicine, this may harm your health.

Interaction with other medicinal products and other types of interactions

The components of the drug (novocaine, anestezin) weaken the antibacterial effect of sulfonamide drugs. Enhance the effects of drugs with local anesthetic action.

If you are taking any other medications at the same time, you should inform your doctor.

Use during pregnancy or breastfeeding

During pregnancy or breastfeeding, the use of the drug is possible only if the expected benefit to the mother outweighs the potential risk to the fetus or child.

Ability to influence reaction speed when driving vehicles or other mechanisms

No effect.

Method of administration and doses

The drug is used externally. Rub painful areas of the skin with Menovazin 2-3 times a day. The course of treatment depends on the form, severity of the disease, the effect of the drug, as well as the nature of the treatment (monotherapy or in combination with other drugs).

Before using Menovazin in a ball bottle for the first time, it is necessary to remove the protective membrane located under the ball nozzle.

Children

Do not use in children under 12 years of age.

Overdose

With prolonged use, dizziness, general weakness, decreased blood pressure, allergic reactions are possible. If such symptoms appear, the drug should be discontinued, the remains should be washed off the skin surface with water, and symptomatic therapy should be carried out.

Side effects

Allergic reactions are possible (hyperemia, skin irritation, itching, rash, edema, urticaria).

If any adverse reactions occur, you should consult a doctor.

Expiration date

For 40 ml or 100 ml bottles – 3 years.

The drug cannot be used after the expiration date indicated on the package.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 C.

Keep out of reach of children.

Packaging

40 ml or 100 ml in bottles; 50 ml in roller bottles.

Vacation category

Without a prescription.

Producer

JSC "Lubnypharm".

Address

Ukraine, 37500, Poltava region, Lubny, Barvinkova st., 16.